McEachron Kim 4
4 · GENOMIC HEALTH INC · Filed Jul 9, 2019
Insider Transaction Report
Form 4
McEachron Kim
Chief People Officer
Transactions
- Sale
Common Stock
2019-07-05$60.01/sh−5,335$320,151→ 36,472 total - Exercise/Conversion
Common Stock
2019-07-05$30.69/sh+5,335$163,731→ 41,807 total - Exercise/Conversion
Employee Stock Option (right to buy)
2019-07-05−5,335→ 9,665 totalExercise: $30.69Exp: 2022-03-12→ Common Stock (5,335 underlying)
Footnotes (5)
- [F1]Includes an aggregate of 11,261 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- [F2]These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on March 18, 2019.
- [F3]Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- [F4]Represents weighted average sale price. Actual sale prices ranged from $60.00 to $60.06.
- [F5]The option became exercisable as to 25% of the shares on March 12, 2013, and became exercisable as to 1/48th of the shares each full month thereafter.